Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
Lukas HartlKatharina HaslingerMartin AngererMathias JachsBenedikt SimbrunnerDavid Josef Maria BauerGeorg SemmlerBernhard ScheinerErnst EigenbauerRobert StrasslMonika BreuerOliver KimbergerDaniel LaxarMichael TraunerMattias MandorferThomas ReibergerPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
Almost half of the COVID-19 patients exhibit abnormal hepatocellular and cholestasis-related liver chemistries with 40-69 years old patients being at particularly high risk for COVID-19-related liver injury and liver-related mortality. Elevated AST and BIL after SARS-CoV-2 infection are independent predictors of mortality, especially in patients aged 40-69 years.